Patents by Inventor Laurie Menger

Laurie Menger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immune Cells Defective for SOCS1
    Publication number: 20230303974
    Abstract: The present invention relates to an engineered immune cell defective for SOCS1. Preferably, said engineered immune cell further comprises a genetically engineered antigen receptor that specifically binds a target antigen. The present invention also relates to a method for obtaining a genetically engineered immune cell comprising a step consisting in inhibiting the expression and/or activity of SOCS1 in the immune cell; and further optionally comprising a step consisting in introducing in the said immune cell a genetically engineered antigen receptor that specifically binds to a target antigen. The invention also encompasses said engineered immune cell for their use in adoptive therapy, notably for the treatment of cancer.
    Type: Application
    Filed: July 30, 2021
    Publication date: September 28, 2023
    Applicants: Institut Curie, Institut National de la Santé et de la Recherche Médicale
    Inventors: Laurie Menger, Silvia Menegatti, Sebastian Amigorena